Every tenth woman is afflicted with breast cancer during her lifetime.The diagnosis and treatment of a patient involves the collaboration of a wide range of specialists.
To improve this situation, VPH-PRISM partners are developing software for X-ray, MRI images, ultrasound, and histology from biopsies, to provide a unified display to spatially superimpose, measure, and manipulate these images. Especially helpful would be the ability to characterize the area surrounding a tumor more accurately. The project will aim to answer the questions: has this tissue changed to such a degree that it must be removed with the tumor during the operation, or can a more local excision, exposing the patient to a less invasive operation, be performed without the risk of recurrence?
To accomplish this, tissue sample pathology slides must be digitized. However, digitization generates large amounts of data, which pathologists can only partially inspect. To solve this, VPH-PRISM experts are also developing software that automatically preselects and preprocesses the data, thereby facilitating the work of the pathologist. If the venture is successful, experts estimate that digital pathology will promote a breakthrough in breast cancer care similar to the effect that the widespread introduction of mammography had on early detection that has occurred over the last 15 years.
The project will explore how a deep understanding of tissue microstructure, gleaned from histology, can aid interpretation of X-ray, MRI, and ultrasound images. Additionally challenging is the presentation of tissue sample images alongside MRI and X-ray images. Experts using computationally intensive algorithms must guarantee that multiple data sets fit perfectly together. Only in this manner can tissue parameters gathered using different scalings be spatially correlated and hence superimposed.The goal is a software tool that supports clinicians when choosing therapy. Patient data should be grouped automatically according to shared criteria. This allows the software to provide clues for optimal chemotherapy, for instance, if a patient with particular tissue characteristics has been assigned to a particular group. This could prove useful for monitoring the progress of therapy more accurately: Is the tumor degenerating as quickly as expected when a patient undergoes a certain type of chemotherapy? If not, then the doctor could cease ineffective therapy in a timely fashion and provide the patient with alternative drugs.
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences